Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Isoetharine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 8/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 3/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.86 |
| ▸ | MAPT | P10636 | 8/20 | 0.86 |
| ▸ | TSHR | P16473 | 6/20 | 0.86 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.86 |
| ▸ | LMNA | P02545 | 5/20 | 0.86 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.86 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.86 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.86 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.86 |
| ▸ | BLM | P54132 | 3/20 | 0.86 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.86 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.86 |
| ▸ | THPO | P40225 | 2/20 | 0.86 |
| ▸ | GAA | P10253 | 2/20 | 0.86 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoetharine SCHEMBL3225540 | 1.00 | ADRB2 (1.00) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL29515330 | 1.00 | ADRB2 (1.00) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL56516 | 1.00 | ADRB2 (1.00) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL21252711 | 1.00 | ADRB2 (1.00) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL3218412 | 1.00 | ADRB2 (1.00) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL211343 | 0.98 | ADRB2 (0.97) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL29380912 | 0.93 | KDM4E (1.00) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL212005 | 0.93 | KDM4E (1.00) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL2407556 | 0.93 | KDM4E (1.00) | ADRB2PTGS2OPRK1SLC6A3KDM4E | |
| Isoetharine SCHEMBL4377543 | 0.92 | KDM4E (0.97) | ADRB2PTGS2OPRK1SLC6A3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12262 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545948-B2 | Identification of novel loci in asthma and methods of use thereof for the diagnosis and treatment of asthma | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-02-10 | — | — | US | claimed |
| US-20260027139-A1 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | VIVUS, INC. | 2026-01-29 | — | — | US | claimed |
| US-12485181-B2 | Polyoxazoline-drug conjugates with novel pharmacokinetic properties | SERINA THERAPEUTICS (AL), INC. (US) | 2025-12-02 | — | — | US | claimed |
| US-12383626-B2 | Polyoxazoline-drug conjugates with novel pharmacokinetic properties | SERINA THERAPEUTICS (AL), INC. (US) | 2025-08-12 | — | — | US | claimed |
| US-12383625-B2 | Polyoxazoline-drug conjugates with novel pharmacokinetic properties | SERINA THERAPEUTICS (AL), INC. (US) | 2025-08-12 | — | — | US | claimed |
| US-20250213647-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA | 2025-07-03 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| WO-2025092300-A1 | USE OF ADRENORECEPTOR AGONISTS IN PROMOTING HEMATOPOIETIC REGENERATION | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2025-05-08 | — | — | WO | claimed |
| US-20250134835-A1 | COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) | CURASEN THERAPEUTICS, INC. | 2025-05-01 | — | — | US | claimed |
| US-20250017878-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | CHRONIC AIRWAY THERAPEUTICS LTD (AU) | 2025-01-16 | — | — | US | claimed |
| US-4980159-A | EFFECTING RETRACTION OF HAIR; AFTERSHAVING LIQUIDS; DEPILATORIES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1990-12-25 | — | — | US | claimed |
| US-4965065-A | ADMINISTERING NONSTEROIDAL ANTIINFLAMMATORY AGENTS WITH BETA ADRENERGIC AGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1990-10-23 | — | — | US | claimed |
| EP-0298984-A1 | COMPOSITIONS OF LIPOSOMES AND $g(b) 2?-RECEPTOR ACTIVE SUBSTANCES | Aktiebolaget Draco (SE) | 1989-01-18 | — | — | EP | claimed |
| EP-0282537-A1 | A NEW SYSTEM FOR ADMINISTRATION OF LIPOSOMES TO MAMMALS | Aktiebolaget Draco (SE) | 1988-09-21 | — | — | EP | claimed |
| WO-1988001862-A1 | A NEW SYSTEM FOR ADMINISTRATION OF LIPOSOMES TO MAMMALS | AKTIEBOLAGET DRACO (SE) | 1988-03-24 | — | — | WO | claimed |
| EP-0260241-A1 | A new system for administration of liposomes to mammals | Aktiebolaget Draco (SE) | 1988-03-16 | — | — | EP | claimed |
| EP-0248150-A1 | Gastroprotective process and compositions | Bristol-Myers Squibb Company (US) | 1987-12-09 | — | — | EP | claimed |
| WO-1987005803-A1 | COMPOSITIONS OF LIPOSOMES AND beta2-RECEPTOR ACTIVE SUBSTANCES | AKTIEBOLAGET DRACO (SE) | 1987-10-08 | — | — | WO | claimed |
| US-4313956-A | Novel sypathomimetic amine prodrugs | INTERX RESEARCH CORP. (US) | 1982-02-02 | — | — | US | claimed |
| US-4153677-A | MICROENCAPSULATED BRONCHODILATOR AGENT, ETHYL CELLULOSE FILM | STERLING DRUG INC. (US) | 1979-05-08 | — | — | US | claimed |